Search results
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 4 days agoThis analysis aims to determine whether Moderna's stock is significantly overvalued by examining its current market performance and intrinsic value. Founded in 2010 and going ...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 5 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Quick takes: Moderna's RSV vaccine, flu-COVID combo vaccines, new polio cases
Center for Infectious Disease Research and Policy· 6 days agoThe FDA has pushed back its review of Moderna's RSV vaccine owing to administrative issues.
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 4 days agoFortunately, there are good reasons to believe the company has what it takes. Moderna is inching...
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 5 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most recent filing ...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 4 days agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: